Siemens Healthineers AG

  • WKN: SHL100
  • ISIN: DE000SHL1006
  • Land: Deutschland

Nachricht vom 21.10.2019 | 17:17

Siemens Healthineers AG: Release of a capital market information

Siemens Healthineers AG / Disclosure pursuant to art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) no. 596/2014 Share buyback - 4th Interim Reporting

21.10.2019 / 17:17
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Disclosure pursuant to art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) no. 596/2014

Share buyback - 4th Interim Reporting

In the time period from 14 October 2019 until and including 18 October 2019, a number of 138,878 shares were bought back within the framework of the share buyback of Siemens Healthineers AG; on 20 September 2019, Siemens Healthineers AG disclosed pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014 (MAR) and Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052 the start of the share buyback on 24 September 2019.

Shares were bought back as follows:

Day of purchase Aggregated volume of shares Weighted average price
10/14/2019 57,644 34.8213
10/15/2019 81,234 35.2074
 

The transactions are published in a detailed form on the website of Siemens Healthineers AG (www.corporate.siemens-healthineers.com/investor-relations).

The total volume of shares which were bought back within the framework of the share buyback in the time period from 24 September 2019 until and including 18 October 2019 amounts to 972,771 shares.

The purchase of the shares of Siemens Healthineers AG is carried out by a credit institution that has been commissioned by Siemens Healthineers AG; the shares are repurchased exclusively on the electronic trading platform of the Frankfurt Stock Exchange (Xetra).

Munich, 21 October 2019
Siemens Healthineers AG
The Managing Board



21.10.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

HELMA Eigenheimbau: Klarer Kauf

Die HELMA Eigenheimbau hat mit dem Zugang weiterer Ferienimmobilienprojekte das potenzielle Umsatzvolumen um 150 Mio. € gesteigert. Ohnehin verfügt die Gesellschaft über einen umfangreichen Grundstücksbestand für das Bauträgergeschäft, womit in den kommenden Geschäftsjahren Umsätze in Höhe von über 1,4 Mrd. € realisiert werden könnten. Damit dürften unsere Schätzungen, in denen wir ein nachhaltiges Überschreiten der Umsatzmarke von 300 Mio. € annehmen, gut unterfüttert sein. Bei einem Kursziel von 65,00 € ist die HELMA-Aktie ein klarer Kauf.

News im Fokus

Deutsche Post AG: Auswirkungen des Corona - Virus und der Entscheidung zu Streetscooter

28. Februar 2020, 14:22

Aktuelle Research-Studie

2G Energy AG

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Hinzufügen

28. Februar 2020